These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2190141)

  • 21. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine.
    Bolotovski VM; Grabowsky M; Clements CJ; Albrecht P; Brenner ER; Zargaryantzs AI; Litvinov SK; Mikheyeva IV
    Int J Epidemiol; 1994 Oct; 23(5):1069-77. PubMed ID: 7860158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 27. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
    Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiences in mass prevention of measles by vaccination.
    Perkins FT
    Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective primary health care: strategies for control of disease in the developing world. IV. Measles.
    Walsh JA
    Rev Infect Dis; 1983; 5(2):330-40. PubMed ID: 6844806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-based comparisons of measles immunization strategies using high dose Edmonston-Zagreb type vaccines.
    McLean AR; Nokes DJ; Anderson RM
    Int J Epidemiol; 1991 Dec; 20(4):1107-17. PubMed ID: 1800411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles outbreaks: who are at risk and why.
    Grimes DE; Woolbert LF
    J Pediatr Health Care; 1989; 3(4):187-93. PubMed ID: 2547055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.
    Samb B; Aaby P; Whittle H; Seck AM; Simondon F
    Trans R Soc Trop Med Hyg; 1993; 87(6):697-701. PubMed ID: 8296384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T
    Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy.
    Tulchinsky TH; Abed Y; Ginsberg G; Shaheen S; Friedman JB; Schoenbaum ML; Slater PE
    Rev Infect Dis; 1990; 12(5):951-8. PubMed ID: 2237137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
    Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
    Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of measles control.
    Cutts FT; Henderson RH; Clements CJ; Chen RT; Patriarca PA
    Bull World Health Organ; 1991; 69(1):1-7. PubMed ID: 2054914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.